Guilbert M - Search Results

1

Evaluation of Strategies for Reducing Vancomycin-Piperacillin/Tazobactam Incompatibility.

Martin Mena A, Négrier L, Treizebré A, Guilbert M, Bonnaire L, Daniau V, Leba Bonki G, Odou P, Genay S, Décaudin B. Martin Mena A, et al. Among authors: guilbert m. Pharmaceutics. 2023 Aug 1;15(8):2069. doi: 10.3390/pharmaceutics15082069. Pharmaceutics. 2023. PMID: 37631283 Free PMC article.

2

Evaluation of the Impact of Infusion Set Design on the Particulate Load Induced by Vancomycin-Piperacillin/Tazobactam Incompatibility.

Négrier L, Décaudin B, Treizebré A, Guilbert M, Odou P, Martin Mena A. Négrier L, et al. Among authors: guilbert m. Pharmaceuticals (Basel). 2024 Sep 17;17(9):1222. doi: 10.3390/ph17091222. Pharmaceuticals (Basel). 2024. PMID: 39338384 Free PMC article.

3

Single preoperative radiation therapy with delayed surgery for low-risk breast cancer: Oncologic outcome, toxicity and cosmesis of the SPORT-DS phase I trial.

Lavigne D, Hijal T, Vavassis P, Guilbert MC, Sideris L, Dubé P, Gervais MK, Leblanc G, Dufresne MP, Nguyen D, Tiberi D, Mahmoud D, Yassa M. Lavigne D, et al. Among authors: guilbert mc. Radiother Oncol. 2024 Nov;200:110515. doi: 10.1016/j.radonc.2024.110515. Epub 2024 Aug 30. Radiother Oncol. 2024. PMID: 39218041 Free article. Clinical Trial.

4

Influence of EGF and pro-NGF on EGFR/SORTILIN interaction and clinical impact in head and neck squamous cell carcinoma.

Morisse M, Bourhis T, Lévêque R, Guilbert M, Cicero J, Palma M, Chevalier D, le Bourhis X, Toillon RA, Mouawad F. Morisse M, et al. Among authors: guilbert m. Front Oncol. 2023 Jul 27;13:661775. doi: 10.3389/fonc.2023.661775. eCollection 2023. Front Oncol. 2023. PMID: 37576898 Free PMC article.

5

Emergency groin hernia: outcome after mesh and non-mesh repair.

Kumar D, Wu D, Tan B, Guilbert M, Muthukumarsamy G. Kumar D, et al. Among authors: guilbert m. ANZ J Surg. 2023 Jan;93(1-2):120-124. doi: 10.1111/ans.18212. Epub 2022 Dec 21. ANZ J Surg. 2023. PMID: 36541911

6

Tumor bed extending to margins in breast cancer specimens after neoadjuvant chemotherapy: Incidence and clinical significance.

Ngo MH, Gervais MK, Leblanc G, Dubé P, Sidéris L, Yassa M, Guilbert MC. Ngo MH, et al. Among authors: guilbert mc. Ann Diagn Pathol. 2022 Dec;61:152060. doi: 10.1016/j.anndiagpath.2022.152060. Epub 2022 Oct 29. Ann Diagn Pathol. 2022. PMID: 36334413

7

Cellular Environment and Phenotypic Heterogeneity: How Data-Driven Modeling Finds the Smoking Gun.

Guilbert M, Courtade E, Thommen Q. Guilbert M, et al. Int J Mol Sci. 2022 Jun 10;23(12):6536. doi: 10.3390/ijms23126536. Int J Mol Sci. 2022. PMID: 35742979 Free PMC article.

8

Tumour response 3 months after neoadjuvant single-fraction radiotherapy for low-risk breast cancer.

Tiberi D, Vavassis P, Nguyen D, Guilbert MC, Simon-Cloutier A, Dubé P, Gervais MK, Sideris L, Leblanc G, Hijal T, Dufresne MP, Yassa M. Tiberi D, et al. Among authors: guilbert mc. Curr Oncol. 2020 Jun;27(3):155-158. doi: 10.3747/co.27.6059. Epub 2020 Jun 1. Curr Oncol. 2020. PMID: 32669925 Free PMC article.

9

Protein level variability determines phenotypic heterogeneity in proteotoxic stress response.

Guilbert M, Anquez F, Pruvost A, Thommen Q, Courtade E. Guilbert M, et al. FEBS J. 2020 Dec;287(24):5345-5361. doi: 10.1111/febs.15297. Epub 2020 Apr 8. FEBS J. 2020. PMID: 32222033 Free article.

10

A Unique Morphological Phenotype in Chemoresistant Triple-Negative Breast Cancer Reveals Metabolic Reprogramming and PLIN4 Expression as a Molecular Vulnerability.

Sirois I, Aguilar-Mahecha A, Lafleur J, Fowler E, Vu V, Scriver M, Buchanan M, Chabot C, Ramanathan A, Balachandran B, Légaré S, Przybytkowski E, Lan C, Krzemien U, Cavallone L, Aleynikova O, Ferrario C, Guilbert MC, Benlimame N, Saad A, Alaoui-Jamali M, Saragovi HU, Josephy S, O'Flanagan C, Hursting SD, Richard VR, Zahedi RP, Borchers CH, Bareke E, Nabavi S, Tonellato P, Roy JA, Robidoux A, Marcus EA, Mihalcioiu C, Majewski J, Basik M. Sirois I, et al. Among authors: guilbert mc. Mol Cancer Res. 2019 Dec;17(12):2492-2507. doi: 10.1158/1541-7786.MCR-19-0264. Epub 2019 Sep 19. Mol Cancer Res. 2019. PMID: 31537618

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

68 results

Search Page

Filters